Results for tag: "Renal Fibrosis Drug"

Renal Fibrosis is a condition in which the kidneys become scarred and hardened, leading to a decrease in their ability to filter waste from the blood. It is a common complication of chronic kidney disease and can lead to kidney failure. Liver and Kidney Disorders Drugs are used to treat a variety of conditions, including renal fibrosis. These drugs can help reduce inflammation, improve kidney function, and slow the progression of the disease. Commonly used drugs include ACE inhibitors, angiotensin receptor blockers, diuretics, and immunosuppressants. The Renal Fibrosis Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs specifically designed to treat renal fibrosis and its associated symptoms. These drugs are used to reduce inflammation, improve kidney function, and slow the progression of the disease. Some companies in the Renal Fibrosis Drug market include AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more